ONCOVIN: VINCRISTINE SULFATE INJECTION.
The VINCRISTINE SULFATE INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: SYRINGE, supplementary_features: ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT, protective_storage_feature: ANTINEOPLASTIC DRUG, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 2.000 MILLILITERS, active_medicament_medicinal_strength: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-227-1609, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | SYRINGE |
| supplementary_features | ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT |
| protective_storage_feature | ANTINEOPLASTIC DRUG |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 3 |
| primary_container_content_quantity | 2.000 MILLILITERS |
| active_medicament_medicinal_strength | 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER |
| part_name_assigned_by_controlling_agency | VINCRISTINE SULFATE INJECTION USP 2ML SYRINGE 3S |
| NSN | 6505-01-227-1609 |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| SUPPLEMENTARY FEATURES | ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | SYRINGE |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | VINCRISTINE SULFATE INJECTION USP 2ML SYRINGE 3S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER |
| TOTAL PRIMARY CONTAINER QUANTITY | 3 |
No substitute or cross-reference records for this part.